Skip to main content

Approach to Chest Pain During Dialysis

  • Chapter
  • First Online:
Interventional Nephrology

Abstract

A patient who complains of chest pain during dialysis represents an immediate challenge. The symptoms may be of benign etiology, but occasionally, they may also be a harbinger of a potential catastrophe. Although mild chest pain or discomfort is reported to occur in 1–4% of dialysis treatments, in light of the high incidence of cardiovascular events and sudden cardiac deaths in dialysis patients, any acute onset of chest pain in a patient on hemodialysis should be attended to promptly. This chapter summarizes the approach, evaluation, differential diagnosis, and management of chest pain during dialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Daugirdas JT, Blake PG, Ing TS. Handbook of dialysis. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. xx. 774 p

    Google Scholar 

  2. Bethesda M. U S Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2011. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

    Google Scholar 

  3. Herzog CA, Littrell K, Arko C, et al. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation. 2007;116:1465–72. 2007/09/06. DOI: CIRCULATIONAHA.107.696765 [pii]10.1161/CIRCULATIONAHA.107.696765

    Article  PubMed  Google Scholar 

  4. Modi KS, Gross D, Davidman M. The patient developing chest pain at the onset of haemodialysis sessions--it is not always angina pectoris. Nephrol Dial Transplant. 1999;14:221–3. 1999/03/03

    Article  CAS  PubMed  Google Scholar 

  5. Kielstein JT, Abou-Rebyeh F, Hafer C, et al. Right-sided chest pain at the onset of haemodialysis. Nephrol Dial Transplant. 2001;16:1493–5. 2001/06/28

    Article  CAS  PubMed  Google Scholar 

  6. Begin V, Ethier J, Dumont M, et al. Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae. Am J Kidney Dis. 2002;40:1277–82. 2002/12/03. DOI: 10.1053/ajkd.2002.36898 S0272-6386(02)00257-3 [pii]

    Article  PubMed  Google Scholar 

  7. Crowley SD, Butterly DW, Peter RH, et al. Coronary steal from a left internal mammary artery coronary bypass graft by a left upper extremity arteriovenous hemodialysis fistula. Am J Kidney Dis. 2002;40:852–5. 2002/09/27. DOI: 10.1053/ajkd.2002.35701 S0272-6386(02)50011-1 [pii]

    Article  PubMed  Google Scholar 

  8. Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–48. 2005/07/22. DOI: 353/3/238 [pii] 10.1056/NEJMoa043545

    Article  CAS  PubMed  Google Scholar 

  9. Fellstrom BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360:1395–407. 2009/04/01. DOI: NEJMoa0810177 [pii] 10.1056/NEJMoa0810177

    Article  CAS  PubMed  Google Scholar 

  10. Chen NX, O’Neill KD, Duan D, et al. Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int. 2002;62:1724–31. 2002/10/10. DOI: kid625 [pii] 10.1046/j.1523-1755.2002.00625.x

    Article  CAS  PubMed  Google Scholar 

  11. Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007;71:438–41. 2007/01/04. DOI: 5002059 [pii] 10.1038/sj.ki.5002059

    Article  CAS  PubMed  Google Scholar 

  12. Schlieper G, Kruger T, Djuric Z, et al. Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int. 2008;74:1582–7. 2008/09/19. DOI: ki2008458 [pii] 10.1038/ki.2008.458

    Article  CAS  PubMed  Google Scholar 

  13. Guyton AC, Sagawa K. Compensations of cardiac output and other circulatory functions in areflex dogs with large A-V fistulas. Am J Phys. 1961;200:1157–63. 1961/06/01

    Article  CAS  Google Scholar 

  14. Gerard M, London APG, Marchais SJ. Hemodynamic overload in end-stage renal disease patients. Semin Dial. 1999;12:77–83. https://doi.org/10.1046/j.1525-139X.1999.00007.x.

    Article  Google Scholar 

  15. Iwashima Y, Horio T, Takami Y, et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis. 2002;40:974–82. 2002/10/31. DOI: 10.1053/ajkd.2002.36329

    Article  CAS  PubMed  Google Scholar 

  16. Korsheed S, Burton JO, McIntyre CW. Higher arteriovenous fistulae blood flows are associated with a lower level of dialysis-induced cardiac injury. Hemodial Int. 2009;13:505–11. 2009/09/18. DOI: HDI384 [pii] 10.1111/j.1542-4758.2009.00384.x

    Article  PubMed  Google Scholar 

  17. Basile C, Lomonte C, Vernaglione L, et al. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant. 2008;23:282–7. 2007/10/19. DOI: gfm549 [pii] 10.1093/ndt/gfm549

    Article  PubMed  Google Scholar 

  18. McIntyre CW, Burton JO, Selby NM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008;3:19–26. 2007/11/16. DOI: CJN.03170707 [pii] 10.2215/CJN.03170707

    Article  PubMed  PubMed Central  Google Scholar 

  19. Burton JO, Jefferies HJ, Selby NM, et al. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4:914–20. 2009/04/10. DOI: CJN.03900808 [pii] 10.2215/CJN.03900808

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dasselaar JJ, Slart RH, Knip M, et al. Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant. 2009;24:604–10. 2008/09/09. DOI: gfn501 [pii] 10.1093/ndt/gfn501

    Article  PubMed  Google Scholar 

  21. Reivich M, Holling HE, Roberts B, et al. Reversal of blood flow through the vertebral artery and its effect on cerebral circulation. N Engl J Med. 1961;265:878–85. 1961/11/02. DOI: 10.1056/NEJM196111022651804

    Article  CAS  PubMed  Google Scholar 

  22. Harjola PT, Valle M. The importance of aortic arch or subclavian angiography before coronary reconstruction. Chest. 1974;66:436–8. 1974/10/01

    Article  CAS  PubMed  Google Scholar 

  23. Tan CS, Fintelmann F, Joe J, et al. Coronary-subclavian steal syndrome in a hemodialysis patient, a case report and review of literature. Semin Dial. 2013;26:E42–6. 2013/03/06. DOI: 10.1111/sdi.12077

    Article  PubMed  Google Scholar 

  24. Gaudino M, Serricchio M, Luciani N, et al. Risks of using internal thoracic artery grafts in patients in chronic hemodialysis via upper extremity arteriovenous fistula. Circulation. 2003;107:2653–5. 2003/05/21. DOI: 10.1161/01.CIR.0000074777.87467.73 01.CIR.0000074777.87467.73 [pii]

    Article  PubMed  Google Scholar 

  25. Kato H, Ikawa S, Hayashi A, et al. Internal mammary artery steal in a dialysis patient. Ann Thorac Surg. 2003;75:270–1. 2003/01/23

    Article  PubMed  Google Scholar 

  26. Lee PY, Ng W, Chen WH. Concomitant coronary and subclavian steal caused by ipsilateral subclavian artery stenosis and arteriovenous fistula in a hemodialysis patient. Catheter Cardiovasc Interv. 2004;62:244–8. 2004/06/02. DOI: 10.1002/ccd.20055

    Article  PubMed  Google Scholar 

  27. Schoenkerman AB, Gimelli G, Yevzlin AS. An interesting case: retrograde blood flow from a LIMA sustaining hemodialysis via an AVF. Semin Dial. 2009;22:566–8. 2009/09/15. DOI: SDI627 [pii] 10.1111/j.1525-139X.2009.00627.x

    Article  PubMed  Google Scholar 

  28. Abdel-Latif A, Mukherjee D, Mesgarzadeh P, et al. Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature. Catheter Cardiovasc Interv. 2010;76:942–8. 2010/05/28. DOI: 10.1002/ccd.22562

    Article  PubMed  Google Scholar 

  29. Manabe S, Shimokawa T, Fukui T, et al. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome? J Card Surg. 2009;24:234–9. 2009/05/15. DOI: JCS789 [pii] 10.1111/j.1540-8191.2008.00789.x

    Article  PubMed  Google Scholar 

  30. Sunagawa G, Komiya T, Tamura N, et al. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg. 2010;89:1896–900; discussion 1900. 2010/05/25. DOI: S0003-4975(10)00493-5 [pii] 10.1016/j.athoracsur.2010.02.080

    Article  PubMed  Google Scholar 

  31. Chang TI, Montez-Rath ME, Tsai TT, et al. Drug-eluting versus bare-metal stents during PCI in patients with end-stage renal disease on dialysis. J Am Coll Cardiol. 2016;67:1459–69. 2016/03/26. DOI: 10.1016/j.jacc.2015.10.104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Khera S, Villablanca PA, Kolte D, et al. Long-term outcomes of drug-eluting stents versus bare-metal stents in end-stage renal disease patients on dialysis: a systematic review and meta-analysis. Cardiol Rev. 2018;26:277–86. 2018/08/30. DOI: 10.1097/CRD.0000000000000192

    Article  PubMed  Google Scholar 

  33. Levine GN, Bates ER, Blankenship JC, et al. ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574-651. 2011/11/09. DOI: CIR.0b013e31823ba622 [pii] 10.1161/CIR.0b013e31823ba622

    PubMed  Google Scholar 

  34. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016;134:e123–55. 2016/03/31. DOI: 10.1161/CIR.0000000000000404

    Article  PubMed  Google Scholar 

  35. Kaufman JS, O'Connor TZ, Zhang JH, et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol. 2003;14:2313–21. 2003/08/26

    Article  CAS  PubMed  Google Scholar 

  36. Wang Q, Xie X, Xu G. The risk of bleeding for antiplatelet agents in haemodialysis patients: a meta-analysis. BMC Nephrol. 2020;21:106. 2020/03/29. DOI: 10.1186/s12882-020-01757-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bangalore S, Maron DJ, O'Brien SM, et al. Management of coronary disease in patients with advanced kidney disease. N Engl J Med. 2020;382:1608–18. 2020/04/01. DOI: 10.1056/NEJMoa1915925

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584–90. 1998/08/27. DOI: 10.1056/NEJM199808273390903

    Article  CAS  PubMed  Google Scholar 

  39. Ginzburg V, Margulis G, Greenberg G, et al. Preserving the left arm vein in cases of hemodialysis access generating left internal mammary artery steal syndrome. J Vasc Access. 2004;5:133–5. 2006/04/06

    Article  CAS  PubMed  Google Scholar 

  40. Ochoa VM, Yeghiazarians Y. Subclavian artery stenosis: a review for the vascular medicine practitioner. Vasc Med. 2011;16:29–34. 2010/11/17. DOI: 1358863X10384174 [pii] 10.1177/1358863X10384174

    Article  PubMed  Google Scholar 

  41. Patel SN, White CJ, Collins TJ, et al. Catheter-based treatment of the subclavian and innominate arteries. Catheter Cardiovasc Interv. 2008;71:963–8. 2008/04/03. DOI: 10.1002/ccd.21549

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Wu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tan, C.S., Covarrubias, D.A., Wu, S. (2022). Approach to Chest Pain During Dialysis. In: Yevzlin, A.S., Asif, A., Salman, L., Ramani, K., Qaqish, S.S., Vachharajani, T.J. (eds) Interventional Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-81155-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81155-6_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81154-9

  • Online ISBN: 978-3-030-81155-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics